Clinical Trial Update: Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for SMT C1100 in pediatric Duchenne muscular dystrophy patients on a balanced diet; the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• SMT C1100 (SMT C1100)

Snippet

Sponsor: Summit Therapeutics | Conditions: Muscular Dystrophy, Duchenne | Phase 1 | Status: COMPLETED